The effect of subthalamic deep brain stimulation on autonomic dysfunction in Parkinson’s disease: clinical and electrophysiological evaluation
- 17 June 2021
- journal article
- research article
- Published by Taylor & Francis in Neurological Research
- Vol. 43 (11) , 894-899
Abstract
Introduction: Subthalamic nucleus (STN) deep brain stimulation (DBS) is an important option in the treatment of motor symptoms and fluctuations in patients with advanced Parkinson’s disease (PD). In addition to the improvement in motor symptoms, many studies have reported changes in some non-motor symptoms (NMS) after STN DBS. Method: 61 patients (42 males) who underwent STN DBS with advanced PD and 24 healthy controls (15 males) were included in the study. Autonomic symptoms (orthostatic hypotension, sweating, salivation) were assessed with a semi-structured questionnaire. Sympathetic skin responses (SSR) were studied by electrophysiological examination within 3–6 months after STN DBS. Results: SSR latency and amplitude were found between the control group and preoperative patients (P ≤ 0.01; p = 0.01, respectively), and between preoperative and postoperative patients (P ≤ 0.01; P ≤ 0.01, respectively). There was a statistically significant difference between the control group and postoperative patients (p = 0.005; p = 0.029, respectively). Orthostatic hypotension (29%) and sweating (48%) improved, but there was no change in the salivation. Discussion: We think that STN DBS applied in PD has not only motor symptoms and fluctuations, but also corrects autonomic dysfunctions such as sweating disorders and orthostatic hypotension; SSR is more sensitive and reliable in detecting autonomic dysfunction, independent of motor symptoms and fluctuations.Keywords
This publication has 31 references indexed in Scilit:
- The prion hypothesis in Parkinson's disease: Braak to the futureActa Neuropathologica Communications, 2013
- Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesisNeurobiology of Disease, 2012
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- The nonmotor symptoms of Parkinson's disease—An overviewMovement Disorders, 2010
- Review: Treatment of dysautonomia in extrapyramidal disordersTherapeutic Advances in Neurological Disorders, 2009
- Sweat testing to evaluate autonomic functionClinical Autonomic Research, 2008
- Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Sweating dysfunction in Parkinson's diseaseMovement Disorders, 2003
- Sympathetic skin responseClinical Autonomic Research, 2003
- Autonomic dysfunction in Parkinson's diseaseNeurological Sciences, 2003